Log in

Relevant bibliographies by topics / 18F-FDG PET/CT; CeCT / Journal articles

To see the other types of publications on this topic, follow the link: 18F-FDG PET/CT; CeCT.

Journal articles on the topic '18F-FDG PET/CT; CeCT'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic '18F-FDG PET/CT; CeCT.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Le Goubey, Jean-Baptiste, Charline Lasnon, Ines Nakouri, et al. "18F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital." Diagnostics 11, no. 7 (2021): 1198. http://dx.doi.org/10.3390/diagnostics11071198.

Full text

Abstract:

Aim: To perform a comprehensive analysis of discordances between contrast-enhanced CT (ceCT) and 18F-FDG PET/CT in the evaluation of the extra-cerebral treatment monitoring in patients with stage IV melanoma. Materials and methods: We conducted a retrospective monocentric observational study over a 3-year period in patients referred for 18F-FDG PET/CT and ceCT in the framework of therapy monitoring of immune checkpoint (ICIs) as of January 2017. Imaging reports were analyzed by two physicians in consensus. The anatomical site responsible for discordances, as well as induced changes in treatmen

APA, Harvard, Vancouver, ISO, and other styles

2

Annunziata, Salvatore, Riccardo Laudicella, Federico Caobelli, Daniele A. Pizzuto, and Young Aimn Working Group. "Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers." Current Radiopharmaceuticals 13, no. 1 (2020): 6–13. http://dx.doi.org/10.2174/1874471012666191015094620.

Full text

Abstract:

Background: 18F-FDG PET/CT has been suggested as an effective tool to stage patients affected by melanoma. In the latest years, new radiopharmaceuticals have been proposed and the use of hybrid PET/ceCT has emerged. Objective: To review recent evidence on the role of PET/CT in melanoma staging as well as its potential for future developments. Methods: A comprehensive computer literature search of PubMed/MEDLINE was carried out to find relevant published articles concerning the feasibility of PET/CT in patients with malignant melanoma. Results: Some recent studies about potentials and limitatio

APA, Harvard, Vancouver, ISO, and other styles

3

Bhosale, Priya, Silanath Peungjesada, Wei Wei, et al. "Clinical Utility of Positron Emission Tomography/Computed Tomography in the Evaluation of Suspected Recurrent Ovarian Cancer in the Setting of Normal CA-125 Levels." International Journal of Gynecologic Cancer 20, no. 6 (2010): 936–44. http://dx.doi.org/10.1111/igc.0b013e3181e82a7f.

Full text

Abstract:

Objectives:This study was conducted to estimate the accuracy of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) as compared with contrast-enhanced CT (CECT) in detecting cancer in patients who have normal cancer antigen (CA)-125 (<35 U/dL) but are suspected of having a recurrent disease based on clinical symptoms.Methods:We retrospectively reviewed the records of patients who had undergone primary cytoreductive surgery and subsequently underwent CECT and FDG-PET/CT for suspected recurrence. [18F]-fluorodeoxyglucose positron emission tomography/computed

APA, Harvard, Vancouver, ISO, and other styles

4

Kajáry, Kornélia, Zsuzsa Molnár, Szabolcs Szakáll jr., Péter Molnár, and Zsolt Lengyel. "Is ceCT necessary beyond FDG-PET/CT for primary staging in Hodgkin lymphoma?" Orvosi Hetilap 155, no. 6 (2014): 226–30. http://dx.doi.org/10.1556/oh.2014.29815.

Full text

Abstract:

Introduction: Several study supported that 18F-Fluoro-deoxy-glucose (FDG) positron emission tomography/computer tomography with low dose CT (standard PET/CT) is more accurate than contrast-enhanced CT (ceCT) in the primary staging of Hodgkin disease. Aim: The authors compared the accuracy of these examinations with this indication in their practice, and analysed the added value of ceCT which was performed as a supplement to standard PET/CT. Method: Twenty-eight patients were categorized based on ceCT, single standard PET/CT and standard PET/CT with ceCT. Results: Twenty-four patients were in t

APA, Harvard, Vancouver, ISO, and other styles

5

Kommi, Sankari, Ramya Priya Rallapeta, Bala Venkat Subramanian, et al. "Utility of [18F]FDG- PET/CT in Initial Staging and Management of Patients with Esophageal Carcinoma: A Tertiary Care Center Experience." Indian Journal of Nuclear Medicine 39, no. 5 (2024): 329–34. https://doi.org/10.4103/ijnm.ijnm_118_23.

Full text

Abstract:

Aim of the Study: This study aims to study the utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) findings in the initial staging and management of patients with esophageal carcinoma. Materials and Methods: In this prospective study, we evaluated 74 patients with a mean age of 59.4 ± 11.6 with a range of 35–86 years. Comparison between the mean and standard deviation of SUVmax of primary tumor between two histopathological groups, squamous cell carcinoma (SCC) and adenocarcinoma (AC) was done using unpaired Student’s t-test. The mean of SUVmax o

APA, Harvard, Vancouver, ISO, and other styles

6

Hildebrandt, Malene Grubbe, Oke Gerke, Christina Baun, et al. "[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy." Journal of Clinical Oncology 34, no. 16 (2016): 1889–97. http://dx.doi.org/10.1200/jco.2015.63.5185.

Full text

Abstract:

Purpose To prospectively investigate the diagnostic accuracy of [18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) with dual-time-point imaging, contrast-enhanced CT (ceCT), and bone scintigraphy (BS) in patients with suspected breast cancer recurrence. Patients and Methods One hundred women with suspected recurrence of breast cancer underwent 1-hour and 3-hour FDG-PET/CT, ceCT, and BS within approximately 10 days. The study was powered to estimate the precision of the individual imaging tests. Images were visually interpreted using a four-point assessmen

APA, Harvard, Vancouver, ISO, and other styles

7

Massollo, Michela, Francesco Fiz, Gianluca Bottoni, et al. "To Enhance or Not to Enhance? The Role of Contrast Medium 18F-FDG PET/CT in Recurrent Ovarian Carcinomas." Medicina 57, no. 6 (2021): 561. http://dx.doi.org/10.3390/medicina57060561.

Full text

Abstract:

Background and Objectives: 18F-fluorodeoxyglucose (FDG) positron emission tomography/X-ray computed tomography (PET/CT) represents the mainstay diagnostic procedure for suspected ovarian cancer (OC) recurrence. PET/CT can be integrated with contrast medium and in various diagnostic settings; however, the effective benefit of this procedure is still debated. We aimed to compare the diagnostic capabilities of low-dose and contrast-enhanced PET/CT (PET/ldCT and PET/ceCT) in patients with suspected ovarian cancer relapse. Materials and Methods: 122 OC patients underwent both PET/ldCT and PET/ceCT.

APA, Harvard, Vancouver, ISO, and other styles

8

Aymard, Samuel, Edmond Rust, Ashjan Kaseb, et al. "Preoperative 18F-FDG PET/CT in Patients with Presumed Localized Colon Cancer: A Prospective Study with Long-Term Follow-Up." Cancers 16, no. 1 (2024): 233. http://dx.doi.org/10.3390/cancers16010233.

Full text

Abstract:

We analyzed whether preoperative 18F-FDG PET/CT adds to conventional primary staging in patients with presumed non-metastatic colonic cancer (CC). The prognostic role of 18F-FDG uptake in the primary tumor was evaluated after a mean follow-up of 15 years. Patients with a new diagnosis of presumed localized CC were prospectively enrolled and underwent presurgical 18F-FDG PET/CT. For each colon lesion, SUVmax, SUVpeak, TLG, and MTV were assessed and tested as prognostic factors. Forty-eight patients were included. Post-surgery pathology identified a total of 103 colon lesions, including 58 invas

APA, Harvard, Vancouver, ISO, and other styles

9

Espitia, Olivier, Jérémy Schanus, Christian Agard, et al. "Semi-Quantitative [18F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis." International Journal of Molecular Sciences 23, no. 24 (2022): 15528. http://dx.doi.org/10.3390/ijms232415528.

Full text

Abstract:

[18F]fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) is used to diagnose large vessel vasculitis in giant cell arteritis (GCA). We aimed to define a semi-quantitative threshold for identifying GCA aortitis from aortic atheroma or the control. Contrast enhanced computed tomography (CECT) was used as the reference imaging for aortic evaluation and to define aortitis, aortic atheroma and control aortas. [18F]FDG-PET/CT was performed on 35 GCA patients and in two different control groups (aortic atheroma (n = 70) and normal control (n = 35)). Aortic semi-quant

APA, Harvard, Vancouver, ISO, and other styles

10

Elgin, OZKAN. "Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence." Stud Stem Cells Res Ther 3, no. 1 (2018): 001–5. https://doi.org/10.17352/sscrt.000010.

Full text

Abstract:

<strong>Aim: </strong>To compare the results of fl uorine-18 (¹8F) fl uorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) and contrast enhanced computed tomography (ceCT) in the assessment of renal cell carcinoma (RCC) recurrences when ceCT had suspected lesions for local recurrence and/or distant metastases.

APA, Harvard, Vancouver, ISO, and other styles

11

Lang, Siegmund, Nike Walter, Stefanie Heidemanns, et al. "[18F]FDG PET/CT Imaging Is Associated with Lower In-Hospital Mortality in Patients with Pyogenic Spondylodiscitis—A Registry-Based Analysis of 29,362 Cases." Antibiotics 13, no. 9 (2024): 860. http://dx.doi.org/10.3390/antibiotics13090860.

Full text

Abstract:

Background: While MRI is the primary diagnostic tool for the diagnosis of spondylodiscitis, the role of [18F]-fluorodeoxyglucose ([18F]FDG) PET/CT is gaining prominence. This study aimed to determine the frequency of [18F]FDG PET/CT usage and its impact on the in-hospital mortality rate in patients with spondylodiscitis, particularly in the geriatric population. Methods: We conducted a Germany-wide cross-sectional study from 2019 to 2021 using an open-access, Germany-wide database, analyzing cases with ICD-10 codes M46.2-, M46.3-, and M46.4- (‘Osteomyelitis of vertebrae’, ‘Infection of interve

APA, Harvard, Vancouver, ISO, and other styles

12

Piccardo, Arnoldo, Francesco Paparo, Riccardo Picazzo, et al. "Value of Fused18F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results." BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/103718.

Full text

Abstract:

Purpose. We compared the accuracy of18F-Choline-PET/MRI with that of multiparametric MRI (mMRI),18F-Choline-PET/CT,18F-Fluoride-PET/CT, and contrast-enhanced CT (CeCT) in detecting relapse in patients with suspected relapse of prostate cancer (PC) after external beam radiotherapy (EBRT). We assessed the association between standard uptake value (SUV) and apparent diffusion coefficient (ADC).Methods. We evaluated 21 patients with biochemical relapse after EBRT. Patients underwent18F-Choline-PET/contrast-enhanced (Ce)CT,18F-Fluoride-PET/CT, and mMRI. Imaging coregistration of PET and mMRI was pe

APA, Harvard, Vancouver, ISO, and other styles

13

Staniuk, T., B. Malkowski, W. Zegarski, E. Srutek, and P. Szlezak. "422. 18F-FLT PET/CT in gastric cancer diagnosis: Comparison of 18F-FLT PET/CT with 18F-FDG PET/CT and CECT." European Journal of Surgical Oncology (EJSO) 40, no. 11 (2014): S161—S162. http://dx.doi.org/10.1016/j.ejso.2014.08.412.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Bruckmann, Nils Martin, Julian Kirchner, Janna Morawitz, et al. "Prospective comparison of CT and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients: Initial results." PLOS ONE 16, no. 12 (2021): e0260804. http://dx.doi.org/10.1371/journal.pone.0260804.

Full text

Abstract:

Objectives To compare the diagnostic accuracy of contrast-enhanced thoraco-abdominal computed tomography and whole-body 18F-FDG PET/MRI in N and M staging in newly diagnosed, histopathological proven breast cancer. Material and methods A total of 80 consecutive women with newly diagnosed and histopathologically confirmed breast cancer were enrolled in this prospective study. Following inclusion criteria had to be fulfilled: (1) newly diagnosed, treatment-naive T2-tumor or higher T-stage or (2) newly diagnosed, treatment-naive triple-negative tumor of every size or (3) newly diagnosed, treatmen

APA, Harvard, Vancouver, ISO, and other styles

15

Strobel, K., C. M. Thuerl, and T. F. Hany. "How much intravenous contrast is needed in FDG-PET/CT?" Nuklearmedizin 44, S 01 (2005): S32—S37. http://dx.doi.org/10.1055/s-0038-1625212.

Full text

Abstract:

Summary:Intravenous, iodinated contrast agents are used routinely for CT (ceCT) imaging but only applied reluctantly for FDGPET/ CT due to possible artefacts. Only for few oncological PET/CT indications, the role of IV contrast agent has been clarified. Essentially, if any knowledge regarding vascular structures or tumour invasion into adjacent structures are needed, a ceCT as part of the combined PET/CT exam should be implemented. However, for some indications like lymphoma, contrast seems not to be necessary. Therefore, imaging procedures for the use of IV contrast for PET/CT have to be adap

APA, Harvard, Vancouver, ISO, and other styles

16

Agrawal, Namita, Tarun Kumar Jain, Abhishek Charan, et al. "Imaging resemblance but diagnostic disparity in cervix cancer: a rare case report." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 9, no. 8 (2020): 3480. http://dx.doi.org/10.18203/2320-1770.ijrcog20203345.

Full text

Abstract:

F-18 FDG PET-CT is an establish modality for staging of cervical cancer. The high uptake value in PET with no evidence of necrosis in CECT is generally understood malignant pathology in known cancer patients. A 47 year-old-female with cervix carcinoma underwent staging FDG PET-CT. It showed FDG avid primary lesion in cervix with FDG avid pelvic, retroperitoneal, mediastinal and supraclavicular lymph nodes. USG guided FNA from the supraclavicular lymph node revealed tuberculosis. Now patient scheduled for ATT and chemotherapy.

APA, Harvard, Vancouver, ISO, and other styles

17

Evangelista, Laura, Filippo Crimì, Andrea Visentin, et al. "[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases." Current Oncology 29, no. 10 (2022): 7887–99. http://dx.doi.org/10.3390/curroncol29100623.

Full text

Abstract:

Aim. The present study aimed to assess the existing data about Primary Adrenal Lymphoma (PAL) evaluated with FDG PET and to describe a small monocentric series of cases. A systematic analysis (from 2010 to 2022) was made by using PubMed and Web of Science databases reporting data about the role of FDG PET/CT in patients with suspicious or known adrenal lymphoma. The quality of the papers was assessed by using QUADAS-2 criteria. Moreover, from a single institutional collection between 2010 and 2021, data from patients affected by adrenal lymphoma and undergoing contrast-enhanced compute tomogra

APA, Harvard, Vancouver, ISO, and other styles

18

Pfluger, T., V. Schneider, M. Hacker, et al. "Restaging of patients with lymphoma." Nuklearmedizin 47, no. 01 (2008): 37–42. http://dx.doi.org/10.3413/nukmed-0114.

Full text

Abstract:

SummaryAim: Assessment of the clinical benefit of i.v. contrast enhanced diagnostic CT (CE-CT) compared to low dose CT with 20 mAs (LD-CT) without contrast medium in combined [18F]-FDG PET/CT examinations in restaging of patients with lymphoma. Patients, methods: 45 patients with non-Hodgkin lymphoma (n = 35) and Hodgkin's disease (n = 10) were included into this study. PET, LD-CT and CECT were analyzed separately as well as side-by-side. Lymphoma involvement was evaluated separately for seven regions. Indeterminate diagnoses were accepted whenever there was a discrepancy between PET and CT fi

APA, Harvard, Vancouver, ISO, and other styles

19

DʼSouza, Maria Mathew, Rajnish Sharma, Anupam Mondal, et al. "Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases." Nuclear Medicine Communications 30, no. 2 (2009): 117–25. http://dx.doi.org/10.1097/mnm.0b013e32831ec57b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Mahato, Abhishek, Richa Joshi, S. Harish, and Dharmesh Paliwal. "Fluorodeoxyglucose positron emission tomography–computed tomography in a pregnant woman with carcinoma breast." World Journal of Nuclear Medicine 20, no. 04 (2021): 374–76. http://dx.doi.org/10.4103/wjnm.wjnm_98_21.

Full text

Abstract:

AbstractA 35-year-old female with a 15-week period of gestation was detected with locally advanced cancer of the left breast. She was suggested to undergo a medical termination of pregnancy (MTP) followed by invasive Oncological imaging - Contrast enhanced computed tomography (CECT) chest–abdomen–pelvis/fluorodeoxyglucose positron emission tomography-CT (FDG PET-CT) for staging the disease. However, to avoid the risk of iatrogenic novel coronavirus 2019 infection to the patient, on her request, the hospital admission was carried out after the oncological workup and thus PET-CT was conducted be

APA, Harvard, Vancouver, ISO, and other styles

21

OZKAN, E., M. ARAZ, C. SOYDAL, and G. ARAS. "Comparison of 18F-FDG PET/CT and ceCT Results in the Assessment of RCC Recurrence." Studies on Stem Cells Research and Therapy 3, no. 1 (2017): 001–5. http://dx.doi.org/10.17352/sscrt.000010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Paone, Gaetano, Mariana Raditchkova-Sarnelli, Anastasios Stathis, Luca Giovanella, Emanuele Zucca, and Luca Ceriani. "Limited Benefit of Additional Contrast-Enhanced CT to End-of- Treatment PET-CT Evaluation in Patients with Follicular Lymphoma." Blood 128, no. 22 (2016): 5925. http://dx.doi.org/10.1182/blood.v128.22.5925.5925.

Full text

Abstract:

Abstract BACKGROUND: Follicular lymphoma (FL) is generally characterized by a moderate metabolic activity (FDG-avidity) in nodal and extra-nodal sites and by the frequent detection of residual disease in post-treatment PET scans. Since median age at diagnosis is over 60 years, in many FL patients several conditions that affect the elderly often occur in combination with the tumor, thus complicating and limiting the use of conventional imaging for lymphoma staging and response assessment. For this reason, the choice of the imaging technique should take into account clinical needs (preservation

APA, Harvard, Vancouver, ISO, and other styles

23

Panebianco, Martina, Oreste Bagni, Natalia Cenfra, et al. "Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin’s lymphoma." Leukemia Research 76 (January 2019): 48–52. http://dx.doi.org/10.1016/j.leukres.2018.11.018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Cimino, Giuseppe, Jan Maciej Zaucha, Cirillo S, et al. "The Complementary Prognostic Role of Baseline and Interim PET in Predicting Treatment Outcome in Advanced-Stage Hodgkin Lymphoma." Blood 124, no. 21 (2014): 4405. http://dx.doi.org/10.1182/blood.v124.21.4405.4405.

Full text

Abstract:

Abstract INTRODUCTION: We retrospectively evaluated the contribution of the positron emission tomography (PET) combined with computed tomography (PET/CT) and contrast enhanced computed tomography (ceCT) in the staging and in the prognostication of untreated advanced Hodgkin’s lymphoma (HL). METHODS: One-hundred-sixty-two HL patients from Italian, Poland and Danish centers entered this study. Treatment consisted on ABVD with or without radiotherapy. All patients were staged at baseline with ceCT and PET/CT (PET-0) and after 2 ABVD with PET/CT (PET-2). All the ceCT and FDG/PET scans were central

APA, Harvard, Vancouver, ISO, and other styles

25

Fukumoto, Chonji, Ryo Oshima, Yuta Sawatani, et al. "Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study." Cancers 13, no. 22 (2021): 5843. http://dx.doi.org/10.3390/cancers13225843.

Full text

Abstract:

Background: The surveillance methods oral squamous cell carcinoma (OSCC) patients may be chosen by considering the risk for recurrence, and it is important to establish appropriate methods during the period in which latent/dormant cancer cells become more apparent. To investigate the appropriate surveillance of patients with OSCC based on the individual risk for recurrence and/or metastasis, we performed a retrospective cohort study after the complete surgical resection of OSCC as the primary treatment. Methods: The study was performed in 324 patients with OSCC who had been primarily treated w

APA, Harvard, Vancouver, ISO, and other styles

26

Morassi, Mauro, Mattia Bonacina, Claudio Bnà, Alberto Zaniboni, and Giordano Savelli. "Dural Metastases of Advanced Prostate Cancer Detected by 18F-Fluorocholine." Diagnostics 10, no. 6 (2020): 385. http://dx.doi.org/10.3390/diagnostics10060385.

Full text

Abstract:

Prostate cancer with extensive dural metastases is very rare, with only few cases described in the literature. We report one such case of a 74-year-old man with advanced prostate cancer, and in relatively good clinical condition. The patient returned with complaints of headache and diplopia. Fluorocholine (18F) chloride (18F-FCH) is an analog of choline in which a hydrogen atom has been replaced by fluorine (18F). After crossing the cell membrane by a carrier-mediated mechanism, choline is phosphorylated by choline kinase to produce phosphorylcholine. 18F-FCH positron emission tomography–compu

APA, Harvard, Vancouver, ISO, and other styles

27

Geboers, Bart, Florentine Timmer, Alette Ruarus, et al. "Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol." Cancers 13, no. 15 (2021): 3902. http://dx.doi.org/10.3390/cancers13153902.

Full text

Abstract:

Irreversible electroporation (IRE) is a novel image-guided tumor ablation technique with the ability to generate a window for the establishment of systemic antitumor immunity. IRE transiently alters the tumor’s immunosuppressive microenvironment while simultaneously generating antigen release, thereby instigating an adaptive immune response. Combining IRE with immunotherapeutic drugs, i.e., electroimmunotherapy, has synergistic potential and might induce a durable antitumor response. The primary objective of this study is to assess the safety of the combination of IRE with IMO-2125 (a toll-lik

APA, Harvard, Vancouver, ISO, and other styles

28

Manickam, GVenkada, Sheh Rawat, PS Choudhury, et al. "A quantitative comparison of gross tumour volumes delineated on [18F]-FDG PET-CT scan and CECT scan in head and neck cancers." Indian Journal of Nuclear Medicine 27, no. 2 (2012): 95. http://dx.doi.org/10.4103/0972-3919.110691.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Termure, Dragos A., Mindra E. Badea, Delia D. Donci, and Gabriel E. Petre. "Artificial Intelligence and radiomics in cervical lymph node staging for head and neck squamous cell carcinoma: a narrative review." Romanian Journal of Stomatology 71, no. 2 (2025): 259–66. https://doi.org/10.37897/rjs.2025.2.18.

Full text

Abstract:

Background and objectives. Cervical lymph node (LN) metastasis significantly impacts prognosis in head and neck squamous cell carcinoma (HNSCC), with extranodal extension (ENE) further worsening outcomes. Conventional imaging often lacks sensitivity and specificity, underscoring the need for improved diagnostic tools. Objective. This narrative review evaluates the role of artificial intelligence (AI), including radiomics and deep learning (DL), in enhancing the detection of cervical LN metastasis in HNSCC. Methods. A targeted literature search was conducted to identify recent studies using AI-

APA, Harvard, Vancouver, ISO, and other styles

30

Gandikota, Neetha, Su Ann Ng, Ryan Cotter, et al. "A combined evaluation strategy of FDG PET/CT and contrast-enhanced diagnostic CT (ceCT) for lymph nodes in the neck." Journal of Clinical Oncology 30, no. 15_suppl (2012): 5578. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.5578.

Full text

Abstract:

5578 Background: Accurate assessment of cervical lymph nodes (LNs) for determination of metastatic involvement is of prime importance for management. Our objective was to determine the incremental value of combining metabolic and morphologic information in the differentiation between benign and malignant LNs. Methods: A total of101 pts with head and neck squamous cell (n=91) or thyroid cancer (n=6) or lymphoma (n=4) were included in the study. PET/CT and neck ceCT were acquired simultaneously or sequentially at staging (n=48) or restaging (n=53). In 131 LNs, variables evaluated includes SUVmax

APA, Harvard, Vancouver, ISO, and other styles

31

Kumar, Rakesh, Anshul Sharma, Pramod Garg, Raju Sharma, and S. Datta-Gupta. "Role of dual-point 18F-FDG-PET/CT in the diagnosis of pancreatic adenocarcinoma, in patients with and without concomitant chronic pancreatitis: Comparison with CECT and EUS." Pancreatology 21, no. 4 (2021): 746–54. http://dx.doi.org/10.1016/j.pan.2021.02.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Kumar, Praveen, Nishikant A. Damle, and Chandrasekhar Bal. "Role of F18-FDG PET/CT in the Staging and Restaging of Esophageal Cancer: A Comparison with CECT." Indian Journal of Surgical Oncology 2, no. 4 (2011): 343–50. http://dx.doi.org/10.1007/s13193-012-0128-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Luminari, Stefano, Annibale Versari, Micol Quaresima, et al. "Role of FDG-PET As Prognostic Indicator in Patients with Follicular Lymphoma(FL) After Immunochemotherapy Induction. A Retrospective Study From the Fondazione Italiana Linfomi." Blood 118, no. 21 (2011): 2636. http://dx.doi.org/10.1182/blood.v118.21.2636.2636.

Full text

Abstract:

Abstract Abstract 2636 Background and objectives: Quality of response assessed with [18F]fluorodeoxyglucose - Positron Emission Tomography (FDG-PET) is confirmed as a strong independent prognostic factor in patients with Hodgkin lymphoma and Diffuse Large B-Cell Lymphoma. Recently the prognostic role of response assessment with PET was also shown in patients with Follicular Lymphoma (FL) (Trotman et al JCO 2011). We conducted a retrospective analysis to investigate the role of FDG-PET after immunochemotherapy in FL. Patients and methods: The study was designed as a retrospective unplanned anal

APA, Harvard, Vancouver, ISO, and other styles

34

Fischerova, Daniela, Filip Frühauf, Andrea Burgetova, Ingfrid S. Haldorsen, Elena Gatti, and David Cibula. "The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023)." Cancers 16, no. 4 (2024): 775. http://dx.doi.org/10.3390/cancers16040775.

Full text

Abstract:

Following the European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) joint guidelines (2018) for the management of patients with cervical cancer, treatment decisions should be guided by modern imaging techniques. After five years (2023), an update of the ESGO-ESTRO-ESP recommendations was performed, further confirming this statement. Transvaginal/transrectal ultrasound (TRS/TVS) or pelvic magnetic resonance (MRI) enables tumor delineation and precise assessment of its local extent, including th

APA, Harvard, Vancouver, ISO, and other styles

35

DeSilva, S., J. Waldron, S. Breen, et al. "58 Radiation target volume delineation (TVD) using FDG-PET and contrast enhanced CT (CECT) for patients with head and neck cancer." Radiotherapy and Oncology 76 (September 2005): S18. http://dx.doi.org/10.1016/s0167-8140(05)80219-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Rayamajhi, Sampanna, Aparna Balachandran, Mathew Katz, Arun Reddy, Eric Rohren, and Priya Bhosale. "Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma." Abdominal Radiology 43, no. 2 (2017): 505–13. http://dx.doi.org/10.1007/s00261-017-1316-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Gnanathayalan, S., K. A. S. Karunanayake, B. M. S. Fernando, B. M. A. Yashodara, and U. Bulugahapitiya. "A Rare Manifestation of a Rare Disease: Ectopic Cushing’s Syndrome Secondary to Olfactory Neuroblastoma." Sri Lanka Journal of Diabetes Endocrinology and Metabolism 15, no. 1 (2024): 33–36. http://dx.doi.org/10.4038/sjdem.v15i1.7514.

Full text

Abstract:

Introduction: Olfactory Neuroblastoma (ONB) is a rare malignant Neuroendocrine tumour. It is rarely reported to cause Ectopic Cushing’s Syndrome (ECS). Here, we report a case of ECS secondary to ONB.Case Description: A 40-year-old lady presented with right sided focal seizures complicated with status epilepticus. She was diagnosed with Diabetes Mellitus with severe hyperglycaemia three weeks prior to this admission and started on insulin therapy. Investigations revealed severe hypokalaemia. MRI brain showed no focal lesions but there was mucosal thickening in the paranasal sinuses. Other elect

APA, Harvard, Vancouver, ISO, and other styles

38

Verhoeff, S. R., S. Es, E. Boon, et al. "Lesion detection by ceCT, 89Zr-girentuximab and FDG PET/CT in newly diagnosed patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC)." Annals of Oncology 29 (October 2018): viii314—viii315. http://dx.doi.org/10.1093/annonc/mdy283.097.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Kolli, Sumanas Gopal Datta. "D1 MTE2 Case 5: An adrenal mass..." Indian Journal of Endocrinology and Metabolism 26, Suppl 1 (2022): S2. http://dx.doi.org/10.4103/2230-8210.342193.

Full text

Abstract:

A 35-year-old woman presented with weight gain (10kg), increased appetite, hirsutism, amenorrhoea, and deepening of voice for 8 months. On examination, blood pressure was 180/110 mm Hg, wide (1.5-2 cm), purple striae over anterior abdomen, hirsutism (mFMG score: 14), temporal baldness, clitoromegaly and proximal myopathy were noticed. Investigations revealed loss of circadian rhythm of cortisol with markedly elevated 24h- urinary cortisol (1371 μg) and serum testosterone (212.20 ng/dl) suggesting adrenocortical carcinoma (ACC). A non-contrast CT Abdomen showed a 65*63 mm well-defined hypo-dens

APA, Harvard, Vancouver, ISO, and other styles

40

Elboga, Umut, Ertan Sahin, Yusuf Burak Cayirli, et al. "Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience." Tomography 8, no. 1 (2022): 293–302. http://dx.doi.org/10.3390/tomography8010024.

Full text

Abstract:

Objective: In this study, we aimed to compare [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging to detect lesions in multiple myeloma. Methods: A total of 14 patients with multiple myeloma who underwent [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging were included in this retrospective study. SUVmax values of [68Ga]FAPI and [18F]FDG were compared according to lesion locations. Also, lesion localization ability of both imaging methods was compared on the patient basis. Results: In 4 of 14 patients, [68Ga]FAPI PET/CT and [18F]FDG PET/CT have not detected any bone lesions. In 8 of the remaining 10 pati

APA, Harvard, Vancouver, ISO, and other styles

41

Zhang, Yin, Yue Chen, Zhanwen Huang, Li Zhang, Qiang Wan, and Lei Lei. "Comparison of 18F-NaF PET/CT and 18F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma." Contrast Media & Molecular Imaging 2018 (September 5, 2018): 1–7. http://dx.doi.org/10.1155/2018/8271313.

Full text

Abstract:

Our study aimed at comparing the diagnostic value of 18F-NaF positron emission tomography-computed tomography (PET/CT) and 18F-fluorodeoxyglucose (FDG) PET/CT for detection of skull-base invasion and osseous metastases in patients with nasopharyngeal carcinoma (NPC). Our study retrospectively analyzed 45 patients with pathologically proven NPC. They all underwent both 18F-NaF PET/CT and 18F-FDG PET/CT within a 7-day interval. Bone metastases were confirmed by follow-up using PET/CT, enhance-contrast computed tomography (CT), and magnetic resonance image (MRI). These two examinations were compa

APA, Harvard, Vancouver, ISO, and other styles

42

Piccardo, A., M. Puntoni, S. Morbelli, et al. "18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT." Nuklearmedizin 54, no. 04 (2015): 163–72. http://dx.doi.org/10.3413/nukmed-0727-15-02.

Full text

Abstract:

SummaryAim: To compare 18F-FDG PET/CT and 18F-NaF PET/CT with respect to disease prognostication and outcome in patients affected by bone metastases from breast cancer (BC). Patients, methods: We retrospectively investigated 32 women with BC and documented bone metastases. Semi-quantitative parameters were applied to 18F-FDG PET/CT and 18F-Na PET/CT in order to evaluate disease extent and tumour metabolism. We used time-to-event analyses (Kaplan Meier and COX proportional hazard methods) to estimate progression-free (PFS) and overall survival (OS) in order to assess the independent prognostic

APA, Harvard, Vancouver, ISO, and other styles

43

Piccardo, A., M. Puntoni, G. Treglia, et al. "Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology." European Journal of Endocrinology 174, no. 5 (2016): 693–703. http://dx.doi.org/10.1530/eje-15-1199.

Full text

Abstract:

Purpose To evaluate the role of 18F-flurodeoxiglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) in predicting malignancy of thyroid nodules with indeterminate cytology. Patients and methods We analysed 87 patients who have been scheduled to undergo surgery for thyroid nodule with indeterminate cytology. All patients underwent 18F-FDG-PET/CT, multiparametric neck ultrasonography (MPUS), and 99mTc-methoxyisobutylisonitrile scintigraphy (99mTc-MIBI-scan). Histopathology was the standard of reference. We compared the sensitivity (SE), specificity (SP), accuracy (AC), positi

APA, Harvard, Vancouver, ISO, and other styles

44

LoGiurato, Brendan, Robert Matthews, Elham Safaie, et al. "18F-FDG PET-CT." Nuclear Medicine Communications 36, no. 9 (2015): 908–13. http://dx.doi.org/10.1097/mnm.0000000000000344.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Leporace, Mario, Ferdinando Calabria, Rosanna Tavolaro, et al. "Emergency findings detected by [18F]-FDG PET/contrast-enhanced CT: A translational approach." Imaging, December 4, 2024. https://doi.org/10.1556/1647.2024.00272.

Full text

Abstract:

AbstractObjective2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ([18F]-FDG PET/CT) can be developed in association with contrast-enhanced CT (ceCT), specifically in oncologic patients. This study aimed to evaluate emergency cases incidentally detected in our clinical practice with [18F]-FDG PET/ceCT.MethodWe retrospectively evaluated 3661 [18F]-FDG PET/ceCT, developed between 2017 and 2023, collecting emergency cases needing prompt treatment.ResultsIn 34/3661 patients (0.9%) an emergency case was recorded, in particular through contrast-enhanced CT, linked to

APA, Harvard, Vancouver, ISO, and other styles

46

Gamal, Gihan Hassan. "The usefulness of 18F-FDG PET/CT in follow-up and recurrence detection for patients with lung carcinoma and its impact on the survival outcome." Egyptian Journal of Radiology and Nuclear Medicine 52, no. 1 (2021). http://dx.doi.org/10.1186/s43055-021-00504-2.

Full text

Abstract:

Abstract Background We assess the usefulness of 18F-FDG PET/CT for detection of recurrent or residual tumor in post treatment patients with NSCLC and comparing the results with CECT, and we evaluate its impact to the clinical assessment and overall survival of lung cancer patients. Results A prospective study of 63 patients with potentially resectable NSCLC, were divided into 2 groups according to the initial staging of the disease and the early response to treatment. Group A (n=29) patients were treated by curative treatment, and group B (n=34) patients were treated by palliative treatment. E

APA, Harvard, Vancouver, ISO, and other styles

47

Wang, Fei, Rui Guo, Yan Zhang, et al. "Value of 18F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With 18F-FDG PET/CT, MRI, and Contrast-Enhanced CT." Frontiers in Oncology 12 (February 28, 2022). http://dx.doi.org/10.3389/fonc.2022.844702.

Full text

Abstract:

ObjectivesTo investigate the value of 18F-FDG PET/MRI in the preoperative assessment of esophageal squamous cell carcinoma (ESCC) and compare it with 18F-FDG PET/CT, MRI, and CECT.MethodsThirty-five patients with resectable ESCC were prospectively enrolled and underwent PET/MRI, PET/CT, and CECT before surgery. The primary tumor and regional lymph nodes were assessed by PET/MRI, PET/CT, MRI, and CECT, respectively, and the diagnostic efficiencies were determined with postoperative pathology as a reference standard. The predictive role of imaging and clinical parameters on pathological staging

APA, Harvard, Vancouver, ISO, and other styles

48

Tsuyoshi, Hideaki, Tetsuya Tsujikawa, Shizuka Yamada, Hidehiko Okazawa, and Yoshio Yoshida. "Diagnostic value of [18F]FDG PET/MRI for staging in patients with ovarian cancer." EJNMMI Research 10, no. 1 (2020). http://dx.doi.org/10.1186/s13550-020-00712-3.

Full text

Abstract:

Abstract Purpose To evaluate the diagnostic potential of PET/MRI with 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG) in ovarian cancer. Materials and methods Participants comprised 103 patients with suspected ovarian cancer underwent pretreatment [18F]FDG PET/MRI, contrast-enhanced CT (ceCT) and pelvic dynamic contrast-enhanced MRI (ceMRI). Diagnostic performance of [18F]FDG PET/MRI and ceMRI for assessing the characterization and the extent of the primary tumor (T stage) and [18F]FDG PET/MRI and ceCT for assessing nodal (N stage) and distant (M stage) metastases was evaluated by two experienced r

APA, Harvard, Vancouver, ISO, and other styles

49

Lee, Elaine Yuen Phin, Philip Pun Ching Ip, Ka Yu Tse, et al. "Prospective validation of the role of PET/CT in detecting disease after neoadjuvant chemotherapy in advanced ovarian cancer." European Radiology, March 9, 2024. http://dx.doi.org/10.1007/s00330-024-10674-y.

Full text

Abstract:

Abstract Objectives The study aimed to compare the diagnostic accuracies of 2-[18F]FDG PET/CT and contrast-enhanced CT (ceCT) after neoadjuvant chemotherapy (NACT) in advanced ovarian cancer (OC). Materials and methods This study consisted historical observational cohort and prospective validation cohort. Patients with newly diagnosed stage III–IV OC scheduled for NACT were recruited, with imaging performed after three to six cycles of NACT before interval debulking surgery. Nineteen regions in the abdominopelvic cavity were scored for the presence and absence of disease, referenced to the int

APA, Harvard, Vancouver, ISO, and other styles

50

Tsuyoshi, Hideaki, Tetsuya Tsujikawa, Shizuka Yamada, Hidehiko Okazawa, and Yoshio Yoshida. "Diagnostic value of 18F-FDG PET/MRI for staging in patients with endometrial cancer." Cancer Imaging 20, no. 1 (2020). http://dx.doi.org/10.1186/s40644-020-00357-4.

Full text

Abstract:

Abstract Background Preoperative accurate assessment of endometrial cancer can assist in the planning of additional surgical options, and in predicting the prognosis. The aim of the present study was to evaluate the diagnostic potential of non-contrast PET/MRI with 18F-fluorodeoxyglucose (18F-FDG) for assessment in preoperative staging of endometrial cancer. Methods Thirty-six patients with biopsy-proven endometrial cancer underwent preoperative 18F-FDG PET/MRI, contrast-enhanced CT (ceCT) and pelvic dynamic contrast-enhanced MRI (ceMRI) for initial staging. The diagnostic performance of 18F-F

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!